ATP Citrate Lyase is a General Tumour Biomarker and Contributes to the Development of Cutaneous Squamous Cell Carcinoma

• Egile Nagusiak: Ruiting Luo (Egilea), Yingjian Huang (Egilea), Ruimin Bai (Egilea), Meng Liu (Egilea), Liang Sun (Egilea), Xiaofei Wang (Egilea), Yan Zheng (Egilea)
• Formatua: Liburua
• Argitaratua: Medical Journals Sweden, 2024-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

ATP citrate lyase, the first rate-limiting enzyme in de novo lipogenesis, plays a crucial role in tumour progression. This study explores ATP citrate lyase's potential as a tumour biomarker and its role in cutaneous squamous cell carcinoma. ATP citrate lyase expression patterns were analysed us...